Clinical Trials Sponsored by MAXIMUS

Total 126 results

University of South Carolina
MAXIMUS

Recruiting

Training Adaptations With and Without Ventilatory Training Device

Healthy

United States
Marinus Pharmaceuticals

Recruiting

Randomized Therapy In Status Epilepticus (RAISE)

Status Epilepticus

United States, Australia, Canada
Marinus Pharmaceuticals

Enrolling by invitation

Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy

Tuberous Sclerosis Complex

United States, Spain, United Kingdom, Australia, China, Italy, Israel, Germany, France, Canada, Belgium
Marinus Pharmaceuticals

Completed

A Clinical Trial of Oral Ganaxolone in Women With Postpartum Depression

Behavioral Symptoms | Depressive Disorder | Depression | Mood Disorders | Pregnancy Complications | Depression, Postpartum | Mental Disorder | Postpartum Disorder | PPD | Postpartum Blues

United States
Marinus Pharmaceuticals

Completed

A Randomized, Controlled Trial of Ganaxolone in Patients With Infantile Spasms

Infantile Spasms

United States
Marinus Pharmaceuticals

Completed

Adjunctive Ganaxolone Treatment (Part A) in TSC Followed by Long-term Treatment (Part B) (TSC)

Tuberous Sclerosis

United States
Marinus Pharmaceuticals

Completed

A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601 (0602)

Epilepsy, Complex Partial

United States
Marinus Pharmaceuticals

Not yet recruiting

To Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ganaxolone Added to Standard of Care in Refractory Status Epilepticus (RSE)

Refractory Status Epilepticus

Spain, Switzerland, Germany, France, Austria, Italy, United Kingdom, Czechia, Croatia, Finland, Belgium, Lithuania, Hungary, Israel, Denmark
Marinus Pharmaceuticals

Recruiting

Safety and Efficacy Study of IV Ganaxolone as Adjuvant Therapy for Established Status Epilepticus (ESE)

Status Epilepticus

United States
Marinus Pharmaceuticals

No longer available

Ganaxolone Expanded Access Program Compassionate Use (CDD)

CDKL5 Disorder
Marinus Pharmaceuticals

Completed

A Clinical Trial of Intravenous (IV) Ganaxolone in Women With Postpartum Depression

Behavioral Symptoms | Mental Disorders | Depressive Disorder | Depression | Mood Disorders | Pregnancy Complications | Depression, Postpartum | Puerperal Disorders | Postpartum | PPD

United States
Marinus Pharmaceuticals

Completed

Study of Adjunctive Ganaxolone Treatment in Female Children With Protocadherin 19 (PCDH19)-Related Epilepsy (Violet Study)

PCDH19-Related Epilepsy

United States, Hungary, Italy, Netherlands, Poland
Marinus Pharmaceuticals

Completed

Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus

Epilepsy | Status Epilepticus | Convulsive Status EPILEPTICUS | Non Convulsive Status Epilepticus

United States
Marinus Pharmaceuticals

Recruiting

Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy (TrustTSC)

Tuberous Sclerosis Complex

United States, Spain, Israel, United Kingdom, Germany, Canada, France, Italy
Marinus Pharmaceuticals

Not yet recruiting

Double-blind, Randomized, Placebo-controlled Trial of Ganaxolone in CDKL5 Deficiency Patients 6 Months to Less Than 2 Years Old

CDKL5 Deficiency Disorder
Marinus Pharmaceuticals

Terminated

A Two-year Open-label Extension Study of Ganaxolone in Patients With Drug-resistant Partial-onset Seizures

Drug Resistant Partial Onset Seizure

United States
Marinus Pharmaceuticals

Terminated

Open-label Extension to Protocol 1042-0500

Infantile Spasms

United States
Marinus Pharmaceuticals

Completed

Study of Adjunctive Ganaxolone Treatment in Children and Young Adults With CDKL5 Deficiency Disorder (Marigold)

CDKL5 Deficiency Disorder

United States, Australia, France, Israel, Italy, Poland, Russian Federation, United Kingdom
Marinus Pharmaceuticals

Completed

Open-Label PoC Trial of Ganaxolone in Children With PCDH19 Female Pediatric Epilepsy and Other Rare Genetic Epilepsies

Epilepsy

United States, Italy
Marinus Pharmaceuticals

Completed

A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures

Partial Epilepsy | Catamenial Epilepsy

United States
Marinus Pharmaceuticals

Completed

Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension

Drug Resistant Partial Onset Seizure

United States, Australia, Russian Federation, Bulgaria, Germany, Poland
Marinus Pharmaceuticals

Completed

Open-label Extension to Protocol 1042-0600

Epilepsies, Partial

United States
Maxima Medical Center

Recruiting

Placenta Perfusion and Sufficiency Study (P2SS)

Pregnancy Related | Female | Human | Placenta Diseases, Diagnosis

Netherlands
Maxima Medical Center

Recruiting

A Pilot Study to Explore the Use of Skin Biopsy as Diagnostic Tool in Anterior Cutaneous Nerve Entrapment Syndrome (ACNES) (Biopsy-ACNES)

Chronic Pain Syndrome | Diagnosis | Nerve Entrapment Syndrome | Anterior Cutaneous Nerve Entrapment Syndrome

Netherlands
Maxima Medical Center

Not yet recruiting

Outcome, Hindsight and Implicit Bias in Emergency Medicine and Medical Disciplinary Law. (OHIBEM)

Emergencies | Implicit Bias
Maxima Medical Center

Not yet recruiting

NIRS and Exercise Intensity in Patients With FLIA

Iliac Artery Occlusion | Iliac Artery Disease | Iliac Artery Stenosis | Near-Infrared Spectroscopy
Maxima Medical Center

Completed

Laparoscopic Appendectomy for Chronic Right Lower Abdominal Pain

Chronic or Recurrent Appendicitis
Maxima Medical Center

Recruiting

Sodium Channel Mutations in Patient With the Anterior Cutaneous Nerve Entrapment Syndrome (ACNES) (Nav-ACNES)

Chronic Pain Syndrome | Nerve Entrapment Syndrome | Anterior Cutaneous Nerve Entrapment Syndrome

Netherlands
Maxima Medical Center

Enrolling by invitation

Impact of Incomplete Endometrial Ablation

Heavy Menstrual Bleeding

Netherlands
Maxima Medical Center

Recruiting

The Effect of MedicijnWijs on Adherence to Azathioprine Therapy in Adolescents With IBD (MEDICATION)

Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis

Netherlands
Maxima Medical Center

Completed

Homebased Training With Telemonitoring Guidance in Low to Moderate Risk Patients Entering Cardiac Rehabilitation (FIT@Home)

Myocardial Infarction | Acute Coronary Syndrome

Netherlands
Maxima Medical Center

Completed

Validation of Two Wrist-worn Devices for the Assessment of Energy Expenditure in Cardiac Patients.

Coronary Artery Disease | Heart Failure With Reduced Ejection Fraction

Netherlands
Maxima Medical Center

Terminated

A Multi-Centre RCT of the Axium® Neurostimulator for the Treatment of Chronic Inguinal Pain Following Surgery (SMASHING)

Chronic Inguinal Pain Refractory to Previous Surgical Intervention (Neurectomy)

Netherlands
Maximos Frountzas

Completed

Hellenic Registry for cIAIs (HERCO-II) (HERCO-II)

Intra-abdominal Infection

Greece
Marius Pharmaceuticals
Syneos Health

Completed

Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men

Hypogonadism, Male

United States
Maximos Frountzas

Completed

Prevention Bundles for SSIs (PREBUSSI).

Surgical Site Infection

Greece
Marius Pharmaceuticals
Syneos Health

Completed

Ambulatory Blood Pressure Monitoring (ABPM) Extension Study of Oral Testosterone Undecanoate in Hypogonadal Men

Hypogonadism, Male

United States
Maximos Frountzas

Completed

Nutritional and Functional Assessment of Patients Undergoing Surgery Due to Gastrointestinal Cancer (NUFAGI). (NUFAGI)

Gastrointestinal Cancer

Greece
Minimus Spine, Inc
genae international,ag

Unknown

Post Market Non-Inferiority Study Comparing Triojection® to Discectomy for Lumbar Disc Herniation

Lumbar Disc Herniation

Greece, Italy, Switzerland
Marius Henriksen

Completed

Progressive Active Exercise After Surgical Rotator Cuff Repair

Rotator Cuff Tear

Denmark
Marius Henriksen

Completed

Technology Assisted Physical Activity Among Hospitalised Patients With Respiratory Disease (TAPAS)

Respiratory Disease

Denmark
Marius Henriksen

Completed

Digital Motivation to Decrease Inactive Behaviour in Patients With Knee Osteoarthritis

Knee Osteoarthritis

Denmark
Marius Henriksen

Completed

Cannabidiol for Fibromyalgia (The CANNFIB Trial) (CANNFIB)

Fibromyalgia

Denmark
Marius Henriksen

Completed

Characteristics of Patients Declining INKA Trial Participation (n-INKA)

Knee Osteoarthritis

Denmark
Marius Henriksen

Terminated

SMS-based Lifestyle Intervention for Patients With Liver Cirrhosis With Previous Hepathic Encephalopathy (SMILE)

Liver Cirrhosis, Alcoholic

Denmark
Marius Henriksen

Terminated

Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure (TOCIVID)

Corona Virus Disease

Denmark
Marius Henriksen

Completed

Blood Pressure Changes During Moderate Intensity Strength Training in Aortic Stent-graft Patients

Aortic Stent Graft

Denmark
Marius Henriksen

Completed

Stretching and Pain Sensitivity

Stretching

Denmark
Marius Henriksen

Not yet recruiting

Metformin Treatment of Patients With Hand Osteoarthritis (METRO)

Hand Osteoarthritis

Denmark
Marius Henriksen

Active, not recruiting

Intensive Diet vs Knee Arthroplasty for Knee Osteoarthritis (INKA)

Knee Osteoarthritis

Denmark

Clinical Trials Sponsored by MAXIMUS

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations